Literature DB >> 25664390

Classification of malignant and benign tumors of the lung by infrared spectral histopathology (SHP).

Ali Akalin1, Xinying Mu2, Mark A Kon3, Ayşegül Ergin4, Stan H Remiszewski4, Clay M Thompson5, Dan J Raz6, Max Diem7, Benjamin Bird, Miloš Miljković.   

Abstract

We report results of a study utilizing a novel tissue classification method, based on label-free spectral techniques, for the classification of lung cancer histopathological samples on a tissue microarray. The spectral diagnostic method allows reproducible and objective classification of unstained tissue sections. This is accomplished by acquiring infrared data sets containing thousands of spectra, each collected from tissue pixels ∼6 μm on edge; these pixel spectra contain an encoded snapshot of the entire biochemical composition of the pixel area. The hyperspectral data sets are subsequently decoded by methods of multivariate analysis that reveal changes in the biochemical composition between tissue types, and between various stages and states of disease. In this study, a detailed comparison between classical and spectral histopathology is presented, suggesting that spectral histopathology can achieve levels of diagnostic accuracy that is comparable to that of multipanel immunohistochemistry.

Entities:  

Mesh:

Year:  2015        PMID: 25664390     DOI: 10.1038/labinvest.2015.1

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  23 in total

1.  Following matrix metalloproteinases activity near the cell boundary by infrared micro-spectroscopy.

Authors:  Silvina Federman; Lisa M Miller; Irit Sagi
Journal:  Matrix Biol       Date:  2002-11       Impact factor: 11.583

2.  Infrared spectroscopic imaging for histopathologic recognition.

Authors:  Daniel C Fernandez; Rohit Bhargava; Stephen M Hewitt; Ira W Levin
Journal:  Nat Biotechnol       Date:  2005-03-27       Impact factor: 54.908

3.  The inherent problem of transflection-mode infrared spectroscopic microscopy and the ramifications for biomedical single point and imaging applications.

Authors:  Paul Bassan; Joe Lee; Ashwin Sachdeva; Juliana Pissardini; Konrad M Dorling; John S Fletcher; Alex Henderson; Peter Gardner
Journal:  Analyst       Date:  2012-10-26       Impact factor: 4.616

4.  Line shape distortion effects in infrared spectroscopy.

Authors:  Miloš Miljković; Benjamin Bird; Max Diem
Journal:  Analyst       Date:  2012-07-18       Impact factor: 4.616

Review 5.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

6.  Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.

Authors:  Nicolas Girard; Charuhas Deshpande; Christopher Lau; David Finley; Valerie Rusch; William Pao; William D Travis
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

Review 7.  Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung.

Authors:  Jaishree Jagirdar
Journal:  Arch Pathol Lab Med       Date:  2008-03       Impact factor: 5.534

8.  Using Fourier transform IR spectroscopy to analyze biological materials.

Authors:  Matthew J Baker; Júlio Trevisan; Paul Bassan; Rohit Bhargava; Holly J Butler; Konrad M Dorling; Peter R Fielden; Simon W Fogarty; Nigel J Fullwood; Kelly A Heys; Caryn Hughes; Peter Lasch; Pierre L Martin-Hirsch; Blessing Obinaju; Ganesh D Sockalingum; Josep Sulé-Suso; Rebecca J Strong; Michael J Walsh; Bayden R Wood; Peter Gardner; Francis L Martin
Journal:  Nat Protoc       Date:  2014-07-03       Impact factor: 13.491

9.  Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis.

Authors:  Jinyoung Yoo; Ji Han Jung; Myung A Lee; Kyung Jin Seo; Byoung Yong Shim; Sung Hwan Kim; Deog Gon Cho; Myeong Im Ahn; Chi Hong Kim; Kyu Do Cho; Seok Jin Kang; Hoon Kyo Kim
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

10.  Infrared micro-spectral imaging: distinction of tissue types in axillary lymph node histology.

Authors:  Benjamin Bird; Milos Miljkovic; Melissa J Romeo; Jennifer Smith; Nicholas Stone; Michael W George; Max Diem
Journal:  BMC Clin Pathol       Date:  2008-08-29
View more
  6 in total

Review 1.  Label-free molecular imaging of the kidney.

Authors:  Boone M Prentice; Richard M Caprioli; Vincent Vuiblet
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

2.  Roadmap on optical sensors.

Authors:  Mário F S Ferreira; Enrique Castro-Camus; David J Ottaway; José Miguel López-Higuera; Xian Feng; Wei Jin; Yoonchan Jeong; Nathalie Picqué; Limin Tong; Björn M Reinhard; Paul M Pellegrino; Alexis Méndez; Max Diem; Frank Vollmer; Qimin Quan
Journal:  J Opt       Date:  2017-07-24       Impact factor: 2.516

3.  Resolving Interobserver Discrepancies in Lung Cancer Diagnoses by Spectral Histopathology.

Authors:  Ali Akalin; Ayşegül Ergin; Stanley Remiszewski; Xinying Mu; Dan Raz; Max Diem
Journal:  Arch Pathol Lab Med       Date:  2018-08-24       Impact factor: 5.534

4.  Quantum Cascade Laser-Based Infrared Microscopy for Label-Free and Automated Cancer Classification in Tissue Sections.

Authors:  Claus Kuepper; Angela Kallenbach-Thieltges; Hendrik Juette; Andrea Tannapfel; Frederik Großerueschkamp; Klaus Gerwert
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

5.  New insights into spectral histopathology: infrared-based scoring of tumour aggressiveness of squamous cell lung carcinomas.

Authors:  Vincent Gaydou; Myriam Polette; Cyril Gobinet; Claire Kileztky; Jean-François Angiboust; Philippe Birembaut; Vincent Vuiblet; Olivier Piot
Journal:  Chem Sci       Date:  2019-03-05       Impact factor: 9.825

Review 6.  Applications of hyperspectral imaging in the detection and diagnosis of solid tumors.

Authors:  Yating Zhang; Xiaoqian Wu; Li He; Chan Meng; Shunda Du; Jie Bao; Yongchang Zheng
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.